Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
Go to Blogger edit html and find these sentences.Now replace these sentences with your own descriptions.This theme is Bloggerized by Lasantha Bandara - Premiumbloggertemplates.com.
The government has launched in-house chemotherapy services at 30 ESIC hospitals across the country, according to an official statement. Union Minister for Labour & Employment Bhupender Yadav on Thursday launched the chemotherapy services during the 191st meeting of the ESI Corporation at ESIC headquarters in New Delhi.
Rival contenders Blackstone, Baring Asia hit pause mode as Cipla valuations soar. Torrent taps PE funds like Warburg Pincus, CVC among others to raise around $1 bn before submitting binding offer by early October.
The Indian government has invited bids for the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), in which it holds a 98.11% stake. The remaining 1.89% is held by Kumaon Mandal Vikas Nigam Ltd (KMVNL). The government plans to disinvest its entire stake in IMPCL through strategic disinvestment with a transfer of management control. IMPCL is a profit-making organization that manufactures ayurvedic and unani medicines and supplies them to all states under the National Ayush Mission.
A new study published in the Journal of the American Heart Association has said that about 1 in 4 women may develop irregular heart rhythms after menopause, with stressful life events and poor sleep being leading factors.
The National Health Service (NHS) England has introduced an innovative anti-cancer injection capable of drastically reducing cancer treatment duration. This revolutionary jab has the potential to curtail treatment time for specific patients by a remarkable 75%.
Johnson & Johnson and Lupin will supply their versions of the tuberculosis drug bedaquiline at a significantly cheaper price in low- and middle-income countries, according to the Stop TB Partnership. The new prices, $130 for J&J and $194 for Lupin for a six-month course of treatment, represent a 55% and 33% reduction, respectively. Bedaquiline is a key part of recommended treatment regimens for drug-resistant TB infections, and this price reduction will help broaden access to the life-saving drug.
Strides Pharma Science Ltd on Wednesday said its wholly-owned arm, Strides Pharma Global Pte. Ltd, Singapore, has received approval from the US health regulator for generic Mycophenolate Mofetil for oral suspension indicated in organ transplant patients to avoid rejection. The approval granted by the US Food & Drug Administration (USFDA) is for Mycophenolate Mofetil for oral suspension of strength 200 mg/ml, Strides Pharma Science said in a regulatory filing.
The company said it aims to revolutionize orthodontic treatment options and that the strategic partnership marks a significant milestone in the advancement of digital dentistry. “With this alliance, we will be able to expand our reach in the Indian market," Captain Vikram Kumar, Co-founder of Rejové Aligners, said in a statement.
The present analyses only included patients who were hospitalised due to Covid-19, and, consequently, the findings cannot be generalised to all patients who had Covid-19. Moderate-to-severe disease, being linked to post discharge all-cause mortality, indicates lingering damage due to Covid-19, it said. Some reports have claimed that the severity of pneumonia had no bearing on post-discharge mortality.
Apollo Group on Monday said it will expand its connected care programme across the country. Apollo Connect aims to create the largest connected healthcare ecosystem in the country, empowering hospitals and nursing homes across metros and non-metros to offer holistic and superior patient care, the healthcare major said in a statement.
Venus Remedies on Monday said it has received approval to market a drug, which prevents blood clots, in Saudi Arabia. The company has received the marketing approval for Enoxaparin in pre-filled syringes, the drug firm said in a statement on Monday.
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA). The New Jersey-based arm of the drug firm is recalling 1,200 bottles of Trandolapril and Verapamil Hydrochloride extended-release tablets, as per the latest Enforcement Report of the US health regulator.
The Indian Association of Physical Medicine and Rehabilitation has written to the Union health minister Mansukh Mandaviya raising concerns over the removal of the specialty of physical medicine and rehabilitation from undergraduate MBBS curriculum. According to the new guidelines issued by the National Medical Commission, three departments - Physical Medicine and Rehabilitation (PMR), Respiratory Medicine, and Emergency Medicine - are not included in the list of departments that every medical college/institution must have.
Sun Pharma is looking to fully acquire its Israel-based unit Taro Pharmaceutical Industries in order to integrate the dermatology business with itself and keep it profitable amid increasing competition in the segment, according to Managing Director Dilip Shanghvi. The Mumbai-based drug major has proposed to fully acquire Taro through a reverse triangular merger.
Malaysia's IHH Healthcare Bhd on Friday said it will acquire the remaining stake in hospital chain operator Ravindranath GE Medical Associates (RGE), held by Ravindranath Kancherla and his affiliates, for around Rs 740 crore. IHH Healthcare has inked the agreement to acquire the stake in RGE through its wholly-owned subsidiary Gleneagles Development.
Lupin on Friday said it has received approval from US FDA to market a generic product, used in the treatment of a lung disease, in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market Pirfenidone tablets in strengths of 267 mg and 801 mg, the Mumbai-based drug maker said in a statement.
Aurobindo Pharma promoters have begun the process of selling a majority stake in its injectables business, Eugia Pharma Specialities, after negotiations with potential suitors failed to meet valuation expectations. The promoters have hired investment bank Moelis to manage the sale.
The National Medical Commission (NMC) has suspended the newly proposed regulations that required doctors to prescribe generic drugs or face penalties. The Indian Medical Association (IMA) had urged the government to withdraw the regulations until the quality of all drugs could be assured. The NMC has now put the regulations on hold and stated that they will not be effective until further notification. The IMA also requested exemptions for professional associations and criticized the prohibition on third-party educational activities sponsored by pharmaceutical companies.
BITS Scientists have developed a portable system that uses 3D printing technology to analyze glucose and lactate levels in sweat samples. The device, which can be connected to smartphones, eliminates the need for blood samples to assess glucose levels and can detect lactate concentration using sweat samples. The researchers are currently working on a wearable version of the device.
The Indian government's mandate for physicians to prescribe only generic drug names is facing challenges in execution, according to Fitch Ratings. The report suggests that a significant decline in sales of branded generics will impact the profitability of Indian pharmaceutical companies, as lower prices will outweigh the benefits of reduced marketing costs. However, Fitch believes that the new guidelines are unlikely to result in an immediate shift away from branded generics.
Torrent Pharmaceuticals on Thursday said that the US Food and Drug Administration (US FDA) has issued an Establishment Inspection Report (“EIR”) for the company's manufacturing facility at Dahej, Gujarat. EIR means closure of inspection.
JB Chemicals & Pharmaceuticals on Wednesday received approval from the US health regulator to market a generic product, used to treat mood disorders, in the American market. The company's product is the generic version of Pfizer's Sinequan capsules which are indicated for the treatment of anxiety, depression, and other target symptoms of psychoneurosis.
Torrent Pharma is reportedly vying to acquire the Hamied family's stake in Cipla, which could become the largest pharmaceutical deal since 2014. If successful, the deal could create India's second-largest drugmaker by revenue. Other potential buyers include Blackstone and Baring PE Asia-EQT. Torrent Pharma is said to be forming a consortium with private equity funds and has approached multiple lenders for funding.
Citing the Mashelkar Report of 2003, it went on to say that the problems in the regulatory system in the country were primarily due to inadequate or weak drug control infrastructure at the state and central levels, inadequate testing facilities, shortage of drug inspectors, non-uniformity of enforcement, lack of specially trained cadres for specific regulatory areas, and the non-existence of a data bank.
COVID infections and hospitalizations have been rising in the United States, Europe and Asia, with more cases in recent months attributed to the EG.5 subvariant - nicknamed as "Eris" - which is a descendant of the Omicron lineage that originally emerged in November 2021.
By 2050, nearly one billion people globally are projected to be living with osteoarthritis, according to a study published in The Lancet Rheumatology journal. The study found that currently, 15% of the world's population aged 30 years or above experience osteoarthritis. The increase in cases is mainly attributed to aging, population growth, and obesity.
US-based Glenmark Pharmaceuticals Inc, a subsidiary of the company, has entered into a three-year deferred prosecution agreement with DOJ involving historical pricing practices by former employees relating to the generic drug pravastatin between 2013 and 2015
The Indian Medical Association (IMA) has vehemently opposed the National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2023, which mandate doctors to prescribe only generic drugs. The other contentious issue discussed during the meeting was medical conferences in five-star hotels with cocktail dinners.
